Literature DB >> 10312592

Treating AIDS: the economic issues.

M Drummond, L Davies.   

Abstract

It is now clear that AIDS is not only a disease of great social concern, but also has major resource implications. A number of analyses of the costs of caring for AIDS sufferers have already been published, relating mainly to the U.S.A. These present a confusing picture to the policy maker as the estimates vary greatly. In addition, treatment patterns are changing rapidly, with consequent impact on costs. Therefore this paper reviews the evidence on the costs of treating AIDS, comparing European data with those from the U.S.A. It also investigates the reasons for variations in cost estimates, the likely impact of changing treatment patterns and the relative 'value for money' from treatment of AIDS, compared with other health care interventions.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Year:  1988        PMID: 10312592     DOI: 10.1016/0168-8510(88)90083-8

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  4 in total

Review 1.  Health economics in HIV disease. A review of the European literature.

Authors:  M Youle; P Trueman; K Simpson
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

2.  Cost effectiveness of antiviral treatment with zalcitabine plus zidovudine for AIDS patients with CD4+ counts less than 300/microliters in 5 European countries.

Authors:  K Simpson; E J Hatziandreu; F Andersson; A Shakespeare; I Oleksy; A N Tosteson
Journal:  Pharmacoeconomics       Date:  1994-12       Impact factor: 4.981

3.  The economic costs of caring for people with HIV infection and AIDS in England and Wales.

Authors:  S Petrou; M Dooley; L Whitaker; E Beck; E Kupek; J Wadsworth; D Miller; A Renton
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

Review 4.  Universal precautions to prevent HIV transmission to health care workers: an economic analysis.

Authors:  S R Stock; A Gafni; R F Bloch
Journal:  CMAJ       Date:  1990-05-01       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.